Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.

Espino M, Abraira V, Arroyo R, Bau L, Camara C, Campos-Ruiz L, Casanova B, Espejo C, Fernandez O, Garcia-Merino A, Garcia-Sanchez MI, Gomez M, Gosis A, Izquierdo G, Meca J, Montalban X, Morandeira F, Olascoaga J, Prada A, Quintana E, Ramio-Torrenta Ll, Rodriguez-Antigueedad A, Salgado G, Santiago JL, Sarasola E, Simo-Castello M, Alvarez-Cermeno JC, Villar LM.

Clin. Chim. Acta. 2015; 438: 67-69. FI: 2.824 (Q1).

Approaching Sentiment Analysis by using semi-supervised learning of multi-dimensional classifiers.

Ortigosa-Hernández J, Diego Rodríguez J, Alzate L, Lucania M, Inza I, Lozano JA.

Neurocomputing. 2012; 92: 98-115. FI: 1.580 (Q2).

A Markovianity based optimisation algorithm

Shakya S, Santana R, Lozano JA.

Genet. Program. Evol. Mach. 2012; 13: 159-195. FI: 1.000 (Q2).

Grp Post-ECTRIMS. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Fernández O, Álvarez-Cermeno JC, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, De las Heras V, García-Merino JA, Hernández-Pérez MA, Izguierdo Go, Meca-Lallana JE, Muñoz-García D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Rodríguez-Antigüedad A, Romero-Pinel L, Sánchez F, Tellez N, Tintore M, Montalban X

Rev. Neurología. 2012; 54: 677-691. FI: 1.218 (Q3).

Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).

Fernández O, Álvarez-Cermeno JC, Arroyo-González R, Brieva L, Iles-Hernández MC, Casanova-Estruch B, Comabella M, De las Heras V, García-Merino JA, Hernández-Pérez M, Izguierdo G, Meca-Lallana JE, Muñoz-García D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Rodríguez-Antigüedad A, Romero-Pinel L, Sánchez F, Tellez N, Tintore M, Montalban X, Post-Ectrims G.

Rev. Neurología. 2012; 54: 734-749. FI: 1.218 (Q3).

Spanish consensus on the use of natalizumab (Tysabri (R) – 2011.

Fernández O, García-Merino JA., Arroyo, R., Álvarez-Cermeno JC., Arbizu T, Izquierdo G, Saiz A, Olascoaga J, Rodríguez-Antigüedad A, Prieto JM, Oreja-Guevarak C, Hernández M A, Montalban X.

Neurología. 2012; 27: 432-441. FI: 0.790 (Q4).

Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate.

Arruti M, Castillo-Triviño T, de la Riva P, Martí-Masso JF, López de Munain A, Olascoaga J.

Rev. Neurología. 2012; 55: 190-192. FI: 1.218 (Q3).

TACI mutation in Good’s Syndrome: In search of a genetic basis.

Sáenz-Cuesta M, Martínez-Pomar N, de Gracia J, Echaniz P, Villegas E, Prada A, Otaegui D, Matamoros N, Cuadrado E.

Clin. Immunol. 2012; 145: 27-30. FI: 4.046 (Q2).

An interactive optimization approach to a real-world oceanographic campaign planning problem.

Ibarbia I, Mendiburu A, Santos M, Lozano JA.

Appl. Intell. 2012; 36: 721-734. FI: 0.849 (Q3).

ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.

Alloza I, Otaegui D, López de Lapuente A, Antigüedad A, Varade J, Nuñez C. Arroyo R, Urcelay E, Fernández O, Leyva L, Fedetz M, Izquierdo G, Lucas M, Oliver-Martos B, Alcina A, Saiz A, Blanco Y, Comabella M, Montalban X, Olascoaga J, Matesanz F, Vandenbroeck K.

Genes Immun. 2012; 13: 253-257. FI: 3.872 (Q1).

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.

Canto E, Reverter F, Morcillo-Suarez C, Matesanz F, Fernández O, Izquierdo G, Vandenbroeck K, Rodríguez-Antigüedad A, Urcelay E, Arroyo R, Otaegui D, Olascoaga J, Saiz A, Navarro A, Sánchez A, Domínguez C, Caminero A, Horga A, Tintore M, Montalban X, Comabella M.

Mult. Scler. J. 2012; 18: 983-990. FI: 4.255 (Q1).

HLA-DRB1*15:01 and multiple sclerosis: a female association?

Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Trivino T, Prada A, Sáenz-Cuesta M, De Juan D, López de Munain A, Olascoaga J, Otaegui D.

Mult. Scler. J. 2012; 18: 569-577. FI: 4.255 (Q1).

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes.

Varade J, Comabella M, Ortiz MA, Arroyo R, Fernández O, Pinto-Medel J, Fedetz M, Izquierdo G, Lucas M, López Gómez C, Catalá Rabasa A, Alcina A, Matesanz F, Alloza I, Antigüedad A, García-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalban X, Vandenbroeck K, Urcelay E.

Mult. Scler. J. 2012; 18: 959-965. FI: 4.255 (Q1).

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes.

Varade J, Comabella M, Ortiz MA, Arroyo R, Fernández O, Pinto-Medel J, Fedetz M, Izquierdo G, Lucas M, López Gómez C, Catalá Rabasa A, Alcina A, Matesanz F, Alloza I, Antigüedad A, García-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalban X, Vandenbroeck K, Urcelay E.

Mult. Scler. J. 2012; 18: 959-965. FI: 4.255 (Q1).